BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 20026776)

  • 1. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs.
    Arslan F; Houtgraaf JH; Keogh B; Kazemi K; de Jong R; McCormack WJ; O'Neill LA; McGuirk P; Timmers L; Smeets MB; Akeroyd L; Reilly M; Pasterkamp G; de Kleijn DP
    Circ Cardiovasc Interv; 2012 Apr; 5(2):279-87. PubMed ID: 22354933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury.
    Mersmann J; Berkels R; Zacharowski P; Tran N; Koch A; Iekushi K; Dimmeler S; Granja TF; Boehm O; Claycomb WC; Zacharowski K
    Crit Care Med; 2010 Mar; 38(3):903-9. PubMed ID: 20081527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation.
    Mersmann J; Habeck K; Latsch K; Zimmermann R; Jacoby C; Fischer JW; Hartmann C; Schrader J; Kirschning CJ; Zacharowski K
    Basic Res Cardiol; 2011 Jan; 106(1):89-98. PubMed ID: 20967453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.
    Favre J; Musette P; Douin-Echinard V; Laude K; Henry JP; Arnal JF; Thuillez C; Richard V
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1064-71. PubMed ID: 17332486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model.
    Aprahamian CJ; Lorenz RG; Harmon CM; Dimmit RA
    Pediatr Crit Care Med; 2008 Jan; 9(1):105-9. PubMed ID: 17906593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
    Timmers L; Sluijter JP; van Keulen JK; Hoefer IE; Nederhoff MG; Goumans MJ; Doevendans PA; van Echteld CJ; Joles JA; Quax PH; Piek JJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2008 Feb; 102(2):257-64. PubMed ID: 18007026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury.
    Yada M; Shimamoto A; Hampton CR; Chong AJ; Takayama H; Rothnie CL; Spring DJ; Shimpo H; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):588-94. PubMed ID: 15457160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
    Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H
    J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
    Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
    Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.
    Oyama J; Blais C; Liu X; Pu M; Kobzik L; Kelly RA; Bourcier T
    Circulation; 2004 Feb; 109(6):784-9. PubMed ID: 14970116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion.
    Mersmann J; Koch A; Tran N; Zimmermann R; Granja TF; Larmann J; Herzog C; Theilmeier G; Bornstein SR; Kirschning CJ; Zacharowski K
    Crit Care Med; 2010 Oct; 38(10):1927-32. PubMed ID: 20855990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
    Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
    Tarzami ST; Miao W; Mani K; Lopez L; Factor SM; Berman JW; Kitsis RN
    Circulation; 2003 Nov; 108(19):2387-92. PubMed ID: 14568904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
    Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
    Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the toll-like receptor 4 Toll/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice.
    Meimei H; Dejin M; Erzhen C; Minmin S; Songyao J; Jianfang L; Hao C
    Crit Care Med; 2014 Feb; 42(2):e123-31. PubMed ID: 24231763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
    Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.